Published in Gene Therapy Weekly, July 11th, 2002
Researchers may need to take a different approach to the delivery of these therapies, according to a study undertaken by a team in London, U.K.
One of the study's investigators, Roth Oakley of King's College Hospital, noted that while preclinical studies of rescue gene therapy have shown benefits in immunodeficient animal models with subcutaneous tumors, in reality radioresistant tumors that may recur after surgery can arise deep within the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.